Giammanco, Antonina
 Distribuzione geografica
Continente #
NA - Nord America 2.885
EU - Europa 1.401
AS - Asia 1.279
SA - Sud America 304
AF - Africa 50
OC - Oceania 6
Totale 5.925
Nazione #
US - Stati Uniti d'America 2.837
SG - Singapore 536
IT - Italia 420
CN - Cina 312
RU - Federazione Russa 290
BR - Brasile 257
HK - Hong Kong 157
DE - Germania 143
PL - Polonia 134
VN - Vietnam 88
GB - Regno Unito 79
FI - Finlandia 78
IE - Irlanda 45
FR - Francia 35
IN - India 32
AT - Austria 29
BE - Belgio 22
CA - Canada 22
NL - Olanda 21
TR - Turchia 21
IQ - Iraq 20
SE - Svezia 20
MX - Messico 19
AR - Argentina 18
RO - Romania 18
BD - Bangladesh 15
JP - Giappone 14
UA - Ucraina 14
ES - Italia 12
ZA - Sudafrica 11
IR - Iran 9
GR - Grecia 8
ID - Indonesia 8
PK - Pakistan 8
EC - Ecuador 7
KR - Corea 7
MA - Marocco 7
SA - Arabia Saudita 7
DZ - Algeria 6
IL - Israele 6
LT - Lituania 6
PT - Portogallo 6
UZ - Uzbekistan 6
CL - Cile 5
EG - Egitto 5
KE - Kenya 5
PE - Perù 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
MY - Malesia 4
TW - Taiwan 4
AZ - Azerbaigian 3
CH - Svizzera 3
CI - Costa d'Avorio 3
CY - Cipro 3
CZ - Repubblica Ceca 3
HU - Ungheria 3
VE - Venezuela 3
AO - Angola 2
GA - Gabon 2
HR - Croazia 2
JM - Giamaica 2
KZ - Kazakistan 2
MM - Myanmar 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PY - Paraguay 2
RE - Reunion 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TG - Togo 2
BH - Bahrain 1
BO - Bolivia 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
HN - Honduras 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
NG - Nigeria 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 5.925
Città #
Ashburn 451
Chandler 322
Singapore 322
Fairfield 268
Houston 164
Hong Kong 153
Seattle 146
Woodbridge 131
Zgierz 115
Wilmington 101
Cambridge 99
Moscow 93
New York 84
Palermo 83
Beijing 71
Medford 64
Ann Arbor 58
Altamura 54
Los Angeles 54
Dublin 42
Des Moines 41
Princeton 40
Dallas 38
Lawrence 37
London 30
Santa Clara 29
Ho Chi Minh City 27
San Diego 25
Hefei 23
São Paulo 23
Buffalo 22
Hanoi 22
Nanjing 22
Rome 21
Brussels 20
The Dalles 20
Ludwigshafen am Rhein 18
Bremen 17
Council Bluffs 17
Milan 17
Helsinki 16
Venice 16
Munich 15
Denver 13
Frankfurt am Main 12
Tokyo 12
Warsaw 12
Boardman 11
Jinan 11
Chicago 10
Lappeenranta 10
Shenyang 10
Atlanta 9
Hebei 9
Nanchang 9
Naples 9
Nuremberg 9
Vienna 9
Boston 8
Changsha 8
Chennai 8
Dearborn 8
Falkenstein 8
Izmir 8
Tianjin 8
Baghdad 7
Belo Horizonte 7
Brooklyn 7
Guangzhou 7
Johannesburg 7
Montreal 7
Orem 7
Phoenix 7
Rio de Janeiro 7
Stockholm 7
Favara 6
Guarulhos 6
Haiphong 6
Mexico City 6
Salt Lake City 6
Tashkent 6
Tehran 6
Turku 6
Amsterdam 5
Biên Hòa 5
Bologna 5
Cagliari 5
Campinas 5
Erbil 5
Lahore 5
Nairobi 5
Ningbo 5
Pune 5
Tel Aviv 5
Toronto 5
Ankara 4
Bexley 4
Casablanca 4
Charlotte 4
Hanover 4
Totale 3.840
Nome #
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 240
Resting energy expenditure and substrate oxidation in malnourished patients with type 1 glycogenosis 231
Baseline metabolic disturbances and the twenty-five years risk of incident cancer in a Mediterranean population 218
Genetic epidemiology of autosomal recessive hypercholesterolemia in Sicily: Identification by next-generation sequencing of a new kindred 218
REDUCTION OF CHOLESTEROL WITH NUTRACEUTICAL: RESULTS OF A DOUBLE BLIND STUDY 209
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 202
Effects of Steatosis on Hepatic Hemodynamics in Patients with Metabolic Syndrome 191
Genotypic and phenotypic characterization of patients with autosomal dominant hypercholesterolemia in sicily 188
Albumin versus solvent/detergent-treated pooled plasma as replacement fluid for long-term plasma exchange therapy in a patient with primary hypertriglyceridemia and recurrent hyperlipidemic pancreatitis 187
Identification of a novel LMF1 nonsense mutation responsible for severe hypertriglyceridemia by targeted next-generation sequencing 181
Novel CREB3L3 Nonsense Mutation in a Family With Dominant Hypertriglyceridemia 162
Liver and statins: a critical appraisal of the evidence 154
Anti-PCSK9 treatment: Is ultra-low LDL always good? 147
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy 145
Is echocardiography mandatory for patients with chronic kidney disease? 145
rs629301 CELSR2 polymorphism confers a ten-year equivalent risk of critical stenosis assessed by coronary angiography 142
Heterogenous forms of dyslipidemiain women with polycystic ovary syndrome 135
The pathophysiology of intestinal lipoprotein production 117
Diagnosis of familial hypercholesterolemia in a large cohort of Italian genotyped hypercholesterolemic patients 117
PULMONARY EMBOLISM IN AN EMERGENCY CARE UNIT: EVALUATION OF PREDICTIVE FACTORS FROM CLINICAL HISTORY AND PHYSICAL EXAM 116
DeepSRE: Identification of sterol responsive elements and nuclear transcription factors Y proximity in human DNA by Convolutional Neural Network analysis 116
An unusual case of chronic diarrhea: a case report 114
Comparison of two polygenic risk score to identify non-monogenic primary hypocholesterolemias in a large cohort of Italian hypocholesterolemic subjects: Polygenic hypocholesterolemias 112
Hyperalphalipoproteinemia and Beyond: The Role of HDL in Cardiovascular Diseases 106
Therapeutic options for homozygous familial hypercholesterolemia: the role of Lomitapide 104
PCSK9-D374Y MEDIATED LDL-R DEGRADATION CAN BE FUNCTIONALLY INHIBITED BY EGF-A AND TRUNCATED EGF-A PEPTIDES. AN IN VITRO STUDY 104
APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism 101
MUTATION IN CANDIDATE GENES ACCOUNT FOR A SMALL MINORITY OF HYPOBETALIPOPROTEINEMIAS AND NGS ANALYSIS SUPPORT POLYGENICITY IN MUTATION-NEGATIVE PATIENTS 101
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 100
MOLECULAR CHARACTERIZATION OF PATIENTS WITH AND WITHOUT CORONARY ARTERY DISEASE WITH "EXTREME LDL-C PHENOTYPES" 100
Valutazione in vivo dello stress ossidativo e dell'attivazione piastrinica nell'ipobetalipoproteinemia familiare: confronto con l'ipercolesterolemia familiare e l'iperalfalipoproteinemia familiare 97
FISIOPATOLOGIA DELLA SINTESI DELLE LIPOPROTEINE INTESTINALI 97
Do genetically determined very high and very low LDL levels contribute to Lp(a) plasma concentration? 96
EFFICACY AND SAFETY OF LOMITAPIDE IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: THE PAN-EUROPEAN RETROSPECTIVE OBSERVATIONAL STUDY 93
PREVALENCE OF STATIN INTOLERANCE IN A COHORT OF OUTPATIENTS IN A LIPID CLINIC 91
Lifestyle versus ezetimibe plus lifestyle in patients with biopsy-proven non-alcoholic steatohepatitis (LISTEN): A double-blind randomised placebo-controlled trial 88
Correlations Between Novel Adiposity Indices and Electrocardiographic Evidence of Left Ventricular Hypertrophy in Individuals with Arterial Hypertension 83
Statin-induced autoimmune myositis: a proposal of an "experience-based" diagnostic algorithm from the analysis of 69 patients 82
Resistive index of ophthalmic artery as an imaging biomarker of hypertension-related vascular and kidney damage 81
EFFECTIVENESS AND SAFETY OF LOMITAPIDE IN A PATIENT WITH FAMILIAL CHYLOMICRONEMIA SYNDROME 80
Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation 79
Derivation and validation of a predictive mortality model of in-hospital patients with Acinetobacter baumannii nosocomial infection or colonization 78
IDENTIFICATION OF P.LEU167DEL APOE GENE MUTATION BY NEXT GENERATION SEQUENCING IN A LARGE HYPERCHOLESTEROLEMIC FAMILY 78
Efficacy and safety of lomitapide in familial chylomicronaemia syndrome 76
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study 71
Factors leading to dissemination of cutaneous anthrax: an international ID-IRI study 63
Lack of phenotypic additive effect of familial defective apolipoprotein B3531 in familial hypercholesterolaemia 57
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study 55
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey 52
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia 51
THE ROLE OF TRANSIENT ELASTOGRAPHY IN NAFLD 49
Intestinal epithelial HuR modulates distinct pathways of proliferation and apoptosis and attenuates small intestinal and colonic tumor development. 49
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study 43
Erdheim-Chester disease as complex clinical presentation and diagnosis: A case report and concise review of literature 43
Six genetic variants are associated with cardiovascular disease independently from canonical risk factors: a new method to refine GWAS results based on the UKBiobank phenotype database 29
Echocardiographic Calcium Score of Aortic Valve Correlates with Coronary Artery Calcium Score in Heterozygous Familial Hypercholesterolemia 16
Coronary Artery Calcium Is Independently Associated with Arterial Stiffness and LDL Cholesterol Burden in Patients with Familial Hypercholesterolemia 14
Clinical and Biochemical Characterization of Fabry Disease Associated GLA Gene Variants: Data From a Large Cohort of 469 Thousand Genotyped Subjects of the UK Biobank Database 11
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 9
Homozygous Familial Hypercholesterolemia Is a Life-Limiting Condition 7
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 7
null 4
Resistive index of ophthalmic artery as an imaging biomarker of hypertension-related vascular and kidney damage 1
Totale 6.333
Categoria #
all - tutte 27.874
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.874


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021256 0 0 0 0 0 42 28 27 33 61 37 28
2021/2022506 13 48 35 6 6 17 20 31 59 111 44 116
2022/2023903 74 174 31 116 67 138 37 79 110 10 33 34
2023/2024494 18 64 46 59 23 127 39 29 9 20 16 44
2024/20251.036 19 90 55 68 40 48 75 85 82 136 155 183
2025/20261.874 299 158 192 310 385 530 0 0 0 0 0 0
Totale 6.333